tiprankstipranks
Zentalis Pharmaceuticals Advances with FDA Approval and Upcoming Data
PremiumCompany AnnouncementsZentalis Pharmaceuticals Advances with FDA Approval and Upcoming Data
2M ago
Zentalis announces FDA lifted partial hold on azenosertib studies
Premium
The Fly
Zentalis announces FDA lifted partial hold on azenosertib studies
2M ago
Zentalis to present preclinical azenosertib data at ESMO
Premium
The Fly
Zentalis to present preclinical azenosertib data at ESMO
3M ago
Zentalis price target lowered to $20 from $25 at Oppenheimer
PremiumThe FlyZentalis price target lowered to $20 from $25 at Oppenheimer
4M ago
Zentalis sees cash runway into mid-2026
Premium
The Fly
Zentalis sees cash runway into mid-2026
4M ago
Zentalis CMO Diana Hausman steps down
Premium
The Fly
Zentalis CMO Diana Hausman steps down
4M ago
Zentalis price target lowered to $12 from $45 at Guggenheim
PremiumThe FlyZentalis price target lowered to $12 from $45 at Guggenheim
5M ago
Zentalis downgraded to Neutral from Buy at UBS
Premium
The Fly
Zentalis downgraded to Neutral from Buy at UBS
5M ago
Zentalis downgraded to Hold from Buy at Jefferies
Premium
The Fly
Zentalis downgraded to Hold from Buy at Jefferies
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100